ClinicalTrials.gg
WithdrawnNCT05798039Updated Nov 19, 2026

ENRICH Nurse-Family Partnership Study

An interventional study of ENRICH in Blood Pressure, Body Composition and Blood Sugar, sponsored by University of Colorado, Denver. Withdrawn at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Primary conditionFeeding BehaviorRegistry: Body WeightReclassifiedWhy we changed it
Registry
Body Weight — the first condition term the registry derived for this study.
ClinicalTrials.gg
Feeding Behavior
Why
  1. Body Weight is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Feeding Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Prevention

How we know

Why this study was withdrawn
Clinical trials data included in record for entire consortium study
Updated Nov 19, 2026Now WithdrawnEnrollment updatedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Feeding Behavior by University of Colorado, Denver — 2 open to participants now, 4 under way, 1 of them phase 3. Feeding Behavior · University of Colorado, Denver.

Started
2023
with 1 other
No phase
6 of 10
none open now
Registered
9th of 10
by date

Among the 10 studies in Feeding Behavior by University of Colorado, Denver, this one is one of 2 that started in 2023, is one of 6 with no phase, and was the 9th registered.

Feeding Behavior

988 studies on the registry are indexed under Feeding Behavior; 177 are open to participants now.

Browse Feeding Behavior studies →

Open to participants now

2 of the 10 studies in Feeding Behavior by University of Colorado, Denver are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 112 Feeding Behavior studies recruiting now, 35 (31%) set no upper age limit and 71 (63%) stop at 75 or younger; 41 take children under 18; 70 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Feeding Behavior by University of Colorado, Denver, or all of them as a file.
02

Study summary

The overarching goal of the proposed study is to develop and test an enrichment to Nurse-Family Partnership (NFP) using an existing, evidence-based program to improve clients' and their children's cardiovascular health from early pregnancy to 24 months postpartum. With support from NFP supervisors and nurses, the investigators will develop new NFP materials promoting healthy diet, activity, sleep, and smoking behaviors, along with optimal weight, glycemia, lipid, and blood pressure profiles. The investigators will conduct a pilot study with up to 40 NFP clients (or women similar to NFP client population) and their nurses to determine feasibility and acceptability of the materials and study protocol.

03

Conditions studied

  • Blood Pressure
  • Body Composition
  • Blood Sugar
  • Body Weight
  • Diet Habit
  • Physical Inactivity

Browse trials for

04

In context

Feeding Behavior Reclassified

988 studies on the registry are indexed under Feeding Behavior; 177 are open to participants now.

Browse Feeding Behavior studies →

Lead sponsor

University of Colorado, Denver is the lead sponsor of 1,547 studies on the registry; 318 are open to participants now.

Of its 148 completed or terminated interventional studies of FDA-regulated products, 93 (63%) have results posted.

Compared within Feeding Behavior, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Body Weight. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant or \<24 months postpartum
  • Aged 18 years or older
  • English- or Spanish-speaking

Exclusion criteria

Exclusion Criteria:

  • \<18 years old
06

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    ENRICHed NFP

    Participants will receive additional heart health-focused materials and guidance in sessions with their nurse home visitor. The nurse will help them choose and work towards behavior goals to support their health. This will include goals for activity, diet, weight, blood pressure, diabetes, smoking, social relationships, sleep, parenting, and getting health care.

    Behavioral: ENRICH

Interventions

  • BehavioralENRICH

    Participants will receive additional heart health-focused materials and guidance in sessions with their nurse home visitor. The nurse will help them choose and work towards behavior goals to support their health. This will include goals for activity, diet, weight, blood pressure, diabetes, smoking, social relationships, sleep, parenting, and getting health care.

    Also known as: NFP-Heart

07

What researchers measure

Primary outcomes

  1. Maternal BMI

    Height and weight will be measured and combined to report BMI

    Time frame: Enrollment

Secondary outcomes

  1. A1C

    Blood draw

    Time frame: Enrollment

  2. Blood pressure

    automatic blood pressure monitor will be used to measure both systolic and diastolic blood pressure

    Time frame: Enrollment

  3. Diet Quality

    Diet will be assessed with 24-hour dietary recalls using the Automated Self-Administered system (ASA24). This system uses the USDA multiple-pass method to query all foods and supplements consumed in the prior 24 hours and produces daily and individual food estimates for macronutrients, micronutrients, and MyPyramid Equivalents (such as servings of vegetables, fruits, whole grains, solid fats, and added sugars)

    Time frame: Enrollment

  4. Physical Activity

    Assessed using the Pregnancy Physical Activity Questionnaire (PPAQ), while adjusting metabolic task equivalents for pregnancy. Investigators will calculate average activity intensity (sedentary to vigorous) and type (household, occupational, exercise, transportation) over the past 3 months at collection point. Physical activity outcomes include daily minutes of sedentary, light, moderate, vigorous, household, occupational, exercise, transportation activity.

    Time frame: Enrollment

  5. Smoking frequency

    Participants will be asked about lifetime and recent (past 6 months) usage of cigarette and marijuana. Smoking outcomes include any smoking in pregnancy (binary) and number of cigarettes (total, trimester-specific).

    Time frame: Enrollment

  6. Maternal adiposity

    Percent of total mass that is fat mass, as measured by air displacement plethysmography using the BOD POD device

    Time frame: Enrollment

  7. Sleep Quality

    Assessed using a sleep questionnaire developed and validated by the NIH Patient Report Outcome Information System (PROMIS), adapted for this study. This form queries daytime and nighttime sleep start times, stop times, and duration, and also collect data on sleep disturbances and sleep-related impairments (trouble falling asleep, staying asleep, number of nighttime awakenings, feeling refreshed upon waking, etc.).

    Time frame: Enrollment

08

Study locations

1 site
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2023 (actual). Primary completion is estimated for Apr 2024, 10 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 22, 2023
First posted
Apr 4, 2023
StartActual
Jun 19, 2023
Primary completionEst.
Apr 30, 2024
CompletionEst.
Apr 30, 2024
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Withdrawn Clinical trials data included in record for entire consortium study
changed Nov 19, 2026
Enrollment
40 (estimated)→0 (actual)
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Recruiting→Withdrawn
    Why stopped Clinical trials data included in record for entire consortium study
    Enrollment 40 (estimated)→0 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05798039
Collaborators
Denver Health and Hospital Authority, National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Sponsor
First posted
Apr 4, 2023
Start date
Jun 19, 2023
Primary completion
Apr 30, 2024 (estimated)
Completion
Apr 30, 2024 (estimated)
Last update
Nov 19, 2026

Study contacts

Mandy Allison, MD, MSPH
principal investigator · University of Colorado, Denver

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion